Commentary: Reduction in C-Peptide Levels and Influence on Pharmacokinetics and Pharmacodynamics of Insulin Preparations: How to Conduct a High-Quality Euglycemic Clamp Study

Detalles Bibliográficos
Autores principales: Liu, Hui, Yu, Hongling, Li, Ting, Yu, Yerong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896261/
https://www.ncbi.nlm.nih.gov/pubmed/35250591
http://dx.doi.org/10.3389/fphar.2022.843658
_version_ 1784663123971538944
author Liu, Hui
Yu, Hongling
Li, Ting
Yu, Yerong
author_facet Liu, Hui
Yu, Hongling
Li, Ting
Yu, Yerong
author_sort Liu, Hui
collection PubMed
description
format Online
Article
Text
id pubmed-8896261
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88962612022-03-05 Commentary: Reduction in C-Peptide Levels and Influence on Pharmacokinetics and Pharmacodynamics of Insulin Preparations: How to Conduct a High-Quality Euglycemic Clamp Study Liu, Hui Yu, Hongling Li, Ting Yu, Yerong Front Pharmacol Pharmacology Frontiers Media S.A. 2022-02-18 /pmc/articles/PMC8896261/ /pubmed/35250591 http://dx.doi.org/10.3389/fphar.2022.843658 Text en Copyright © 2022 Liu, Yu, Li and Yu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Liu, Hui
Yu, Hongling
Li, Ting
Yu, Yerong
Commentary: Reduction in C-Peptide Levels and Influence on Pharmacokinetics and Pharmacodynamics of Insulin Preparations: How to Conduct a High-Quality Euglycemic Clamp Study
title Commentary: Reduction in C-Peptide Levels and Influence on Pharmacokinetics and Pharmacodynamics of Insulin Preparations: How to Conduct a High-Quality Euglycemic Clamp Study
title_full Commentary: Reduction in C-Peptide Levels and Influence on Pharmacokinetics and Pharmacodynamics of Insulin Preparations: How to Conduct a High-Quality Euglycemic Clamp Study
title_fullStr Commentary: Reduction in C-Peptide Levels and Influence on Pharmacokinetics and Pharmacodynamics of Insulin Preparations: How to Conduct a High-Quality Euglycemic Clamp Study
title_full_unstemmed Commentary: Reduction in C-Peptide Levels and Influence on Pharmacokinetics and Pharmacodynamics of Insulin Preparations: How to Conduct a High-Quality Euglycemic Clamp Study
title_short Commentary: Reduction in C-Peptide Levels and Influence on Pharmacokinetics and Pharmacodynamics of Insulin Preparations: How to Conduct a High-Quality Euglycemic Clamp Study
title_sort commentary: reduction in c-peptide levels and influence on pharmacokinetics and pharmacodynamics of insulin preparations: how to conduct a high-quality euglycemic clamp study
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896261/
https://www.ncbi.nlm.nih.gov/pubmed/35250591
http://dx.doi.org/10.3389/fphar.2022.843658
work_keys_str_mv AT liuhui commentaryreductionincpeptidelevelsandinfluenceonpharmacokineticsandpharmacodynamicsofinsulinpreparationshowtoconductahighqualityeuglycemicclampstudy
AT yuhongling commentaryreductionincpeptidelevelsandinfluenceonpharmacokineticsandpharmacodynamicsofinsulinpreparationshowtoconductahighqualityeuglycemicclampstudy
AT liting commentaryreductionincpeptidelevelsandinfluenceonpharmacokineticsandpharmacodynamicsofinsulinpreparationshowtoconductahighqualityeuglycemicclampstudy
AT yuyerong commentaryreductionincpeptidelevelsandinfluenceonpharmacokineticsandpharmacodynamicsofinsulinpreparationshowtoconductahighqualityeuglycemicclampstudy

Ejemplares similares